← Leaderboards
Murray Korc
University Of California Irvine
$11,956,061
Attributed
$11,956,061
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,195,911 · 9
By mechanism
R01$8,858,316 · 4
R37$2,201,455 · 1
R21$778,314 · 2
P20$239,850 · 1
P30$117,976 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Irvine
Same institution · by research overlap
- Daniele Piomelli$28,091,294
- Andrea Joan Tenner$14,666,043
- Michael D Cahalan$19,401,862
- Carl W Cotman$34,047,198
- David A Fruman$9,763,991
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCancer CellMalignant Neoplasm Of PancreasCellsMalignant NeoplasmsBaseMouse ModelSignal TransductionBiologicalNeoplasm MetastasisPancreatic Ductal AdenocarcinomaApoptosisCell LinePancreasIncidenceIn VitroMolecularGrowthMutateMediatingSignal PathwayProtein IsoformsOverexpressionGrowth Factor Receptors
Grant awards (47)
Tumor Microenvironment and Metastasis Program$29,494
P30 · FY2022 · CA · contact PI
Tumor Microenvironment and Metastasis Program$29,494
P30 · FY2021 · CA · contact PI
Tumor Microenvironment and Metastasis Program$29,494
P30 · FY2020 · CA · contact PI
Tumor Microenvironment and Metastasis Program$29,494
P30 · FY2019 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$441,940
R01 · FY2018 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$3,579
R01 · FY2018 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$441,940
R01 · FY2017 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$49,543
R01 · FY2017 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$441,940
R01 · FY2016 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$58,398
R01 · FY2016 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$441,940
R01 · FY2015 · CA · contact PI
Novel aspects of Epithelial-Mesenchymal Transition(EMT)in pancreatic cancer$54,821
R01 · FY2015 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$441,940
R01 · FY2014 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$400,151
R37 · FY2012 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$417,605
R37 · FY2011 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$452,707
R37 · FY2010 · CA · contact PI
Role of microRNAs in genetic mouse models of pancreatic cancer$139,113
R21 · FY2010 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$462,645
R37 · FY2009 · CA · contact PI
Role of microRNAs in genetic mouse models of pancreatic cancer$243,448
R21 · FY2009 · CA · contact PI
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma$143,910
R21 · FY2009 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$103,558
R37 · FY2009 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$364,789
R37 · FY2008 · CA · contact PI
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma$251,843
R21 · FY2008 · CA · contact PI
Role of Glypican-1 in Pancreatic Cancer$320,862
R01 · FY2007 · CA · contact PI
Role of Neuropillins in Pancreatic Cancer$300,000
R01 · FY2007 · CA · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$347,417
R01 · FY2006 · CA · contact PI
Role of Glypican-1 in Pancreatic Cancer$330,445
R01 · FY2006 · CA · contact PI
Role of Neuropillins in Pancreatic Cancer$308,960
R01 · FY2006 · CA · contact PI
CTSA Planning at Dartmouth Medical School$239,850
P20 · FY2006 · RR · contact PI
Dysregulation of TGF Beta Action Pancreatic Cancer$355,406
R01 · FY2005 · CA
Role of Glypican-1 in Pancreatic Cancer$338,053
R01 · FY2005 · CA
Role of Neuropillins in Pancreatic Cancer$316,395
R01 · FY2005 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER$264,950
R01 · FY2005 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer$351,749
R01 · FY2004 · CA
Role of Glypican-1 in Pancreatic Cancer$351,244
R01 · FY2004 · CA
Role of Neuropillins in Pancreatic Cancer$316,395
R01 · FY2004 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER$263,248
R01 · FY2004 · CA
Role of Glypican-1 in Pancreatic Cancer$327,233
R01 · FY2003 · CA
Role of Neuropillins in Pancreatic Cancer$316,395
R01 · FY2003 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER$249,664
R01 · FY2003 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer$209,148
R01 · FY2003 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer$119,689
R01 · FY2003 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer$326,487
R01 · FY2002 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER$249,664
R01 · FY2002 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER$267,318
R01 · FY2001 · CA
DYSREGULATION OF TGF-BETA ACTIONS IN PANCREATIC CANCER$188,039
R01 · FY2000 · CA
EPIDERMAL GROWTH FACTOR AND PANCREATIC CANCER$63,514
R01 · FY2000 · CA